Cabazitaxel Viatris 60 mg/3 ml
Cabazitaxel Viatris 60 mg/3 ml is a medicine authorised by Swissmedic under authorisation number 69122. The authorisation holder is Viatris Pharma GmbH. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 30 March 2023 and the authorisation is limited until 29 March 2028. ATC code L01CD04 places the medicine in the group Antineoplastic agents.
| Authorisation number | 69122 |
|---|---|
| Name | Cabazitaxel Viatris 60 mg/3 ml |
| Full name | Cabazitaxel Viatris 60 mg/3 ml, Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Viatris Pharma GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01CD04 |
| First authorisation | 30 March 2023 |
| Authorisation validity | 29 March 2028 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Cabazitaxel Viatris 60 mg/3 ml, Konzentrat zur Herstellung einer Infusionslösung | A | 30 March 2023 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | L01CD04 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Cabazitaxel Viatris 60 mg/3 ml authorised in Switzerland?
Yes. Cabazitaxel Viatris 60 mg/3 ml is authorised by Swissmedic under authorisation number 69122, data as of 01 September 2026. The authorisation is limited until 29 March 2028.
Which dispensing category does Cabazitaxel Viatris 60 mg/3 ml have?
Cabazitaxel Viatris 60 mg/3 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Cabazitaxel Viatris 60 mg/3 ml?
The authorisation holder is Viatris Pharma GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.